Condition

Fibrodysplasia Ossificans Progressiva

Treatments and trials tagged Fibrodysplasia Ossificans Progressiva. Filter by country, access level, or patient stories.

All latest →

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States

Once-Daily Pill for FOP Bone Growth in Teens and Adults

Atebrioz (zilurgisertib) — oral ALK2 inhibitor to reduce new heterotopic ossification in FOP (ages 12+)

Atebrioz (zilurgisertib) is a once-daily pill for fibrodysplasia ossificans progressiva in people 12 and older.

This is for teens 12 and older and adults with fibrodysplasia ossificans progressiva (FOP) — and caregivers — who need a labelled way to slow new extra bone…

September 30, 2026

FDA ApprovedUnited States

New Infusion When Soft Tissue Turns to Bone (Adult FOP)

Pasatru (garetosmab-grts) for adults with fibrodysplasia ossificans progressiva (FOP)

The FDA labelled an intravenous activin A–blocking monoclonal antibody on 19 August 2026 to reduce formation of new heterotopic ossification (HO) lesions and…

Pasatru (garetosmab) is an infusion every 4 weeks for adults with fibrodysplasia ossificans progressiva.

September 7, 2026